Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

Epigenetics

Volumn 6, Issue 12, 2011, Pages 1444-1453

  del Bove, Jessica ^a,f   Rosson, Gary ^a,b   Strobeck, Matthew ^c   Chen, Jianguang ^d   Archer, Trevor K ^d   Wang, Weidong ^e   Knudsen, Erik S ^c   Weissman, Bernard E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

BAF155; Cancer epigenetics; SMARCC1; SWI SNF; Tumor suppressor gene

Indexed keywords

MESSENGER RNA; PROTEASOME; PROTEIN SWI; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SNF;

APOPTOSIS; ARTICLE; BAF155 TUMOR SUPPRESSOR GENE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE ARREST; COLONY FORMATION; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; GROWTH INHIBITION; HETEROZYGOTE; HUMAN; HUMAN CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SENESCENCE; SMARCC1 TUMOR SUPPRESSOR GENE; TUMOR SUPPRESSOR GENE;

EID: 83255184470     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.12.18492     Document Type: Article

References (49)

1. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21-33; http://dx.doi.org/10.1038/nrg1748.
2. Weissman B, Knudsen KE. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res 2009; 69:8223-30; http://dx.doi.org/10.1158/0008-5472.CAN-09-2166.
3. Sudarsanam P, Iyer VR, Brown PO, Winston F. Whole-genome expression analysis of snf/swi mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci USA 2000; 97:3364-9; http://dx.doi.org/10.1073/pnas.050407197.
4. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, et al. A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 2000; 6:1287-95; http://dx.doi.org/10.1016/S1097-2765(00)00127-1.
5. Guidi CJ, Sands AT, Zambrowicz BP, Turner TK, Demers DA, Webster W, et al. Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol 2001; 21:3598-603; http://dx.doi.org/10.1128/MCB.21.10.3598-603.2001.
6. Kim JK, Huh SO, Choi H, Lee KS, Shin D, Lee C, et al. srg3, a mouse homolog of yeast SW13, Is essential for early embryogenesis and involved in brain development. Mol Cell Biol 2001; 21:7787-95; http://dx.doi.org/10.1128/MCB.21.22.7787-95.2001.
7. Klochendler-Yeivin A, Fiette L, Barra J, Muchardt C, Babinet C, Yaniv M. The murine SNF5/INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep 2000; 1:500-6.
8. Roberts CW, Galusha S, McMenamin M, Fletcher C, Orkin SH. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci USA 2000; 97:13796-800; http://dx.doi.org/10.1073/pnas.250492697.
9. Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther 2009; 8:412-6; http://dx.doi.org/10.4161/cbt.8.5.8019.
10. Bultman SJ, Herschkowitz JI, Godfrey V, Gebuhr TC, Yaniv M, Perou CM, et al. Characterization of mammary tumors from Brg1 heterozygous mice. Oncogene 2008; 27:460-8; http://dx.doi.org/10.1038/sj.onc.1210664.
11. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Re-expression of hSNF5/INI1/ BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 2002; 21:5193-203; http://dx.doi.org/10.1038/sj.onc.1205706.
12. Bochar DA, Wang L, Beniya H, Kinev A, Xue Y, Lane WS, et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 2000; 102:257-65; http://dx.doi.org/10.1016/S0092-8674(00)00030-1.
13. Gartel AL, Shchors K. Mechanisms of c-myc mediated transcriptional repression of growth arrest genes. Exp Cell Res 2003; 283:17-21; http://dx.doi.org/10.1016/S0014-4827(02)00020-4.
14. Lee D, Kim JW, Seo T, Hwang SG, Choi EJ, Choe J. SWI/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem 2002; 277:22330-7; http://dx.doi.org/10.1074/jbc.M111987200.
15. Hendricks KB, Shanahan F, Lees E. Role for BRG1 in cell cycle control and tumor suppression. Mol Cell Biol 2004; 24:362-76; http://dx.doi.org/10.1128/MCB.24.1.362-76.2004.
16. p21CIP1/WAF1/SDI. Mol Cell Biol 2004; 24:1188-99; http://dx.doi.org/10.1128/MCB.24.3.1188-99.2004.
17. Zhang HS, Gavin M, Dahiya A, Postigo AA, Ma D, Luo RX, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101:79-89; http://dx.doi.org/10.1016/S0092-8674(00)80625-X.
18. Hong CY, Suh JH, Kim K, Gong EY, Jeon SH, Ko M, et al. Modulation of androgen receptor transactivation by the SWI3-related gene product (SRG3) in multiple ways. Mol Cell Biol 2005; 25:4841-52; http://dx.doi.org/10.1128/MCB.25.12.4841-52.2005.
19. Ko M, Jang J, Ahn J, Lee K, Chung H, Jeon SH, et al. T cell receptor signaling inhibits glucocorticoidinduced apoptosis by repressing the SRG3 expression via Ras activation. J Biol Chem 2004; 279:21903-15; http://dx.doi.org/10.1074/jbc.M402144200.
20. Maitra A, Wistuba I, Washington C. Hgh-resoution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001; 159:119-30; http://dx.doi.org/10.1016/S0002-9440(10)61679-3.
21. Wistuba II, Gazdar A, Minna J. Molecular genetics of small cell lung carcinoma. Semin Oncol 2001; 28:3-13; http://dx.doi.org/10.1016/S0093-7754(01)90072-7.
22. Andersen CL, Christensen LL, Thorsen K, Schepeler T, Sorensen FB, Verspaget HW, et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. Br J Cancer 2009; 100:511-23 http://dx.doi.org/10.1038/sj.bjc.6604884.
23. Heebøll S, Borre M, Ottosen PD, Andersen CL, Mansilla F, Dyrskjot L, et al. SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiation. Histol Histopathol 2008; 23:1069-76.
24. Ralhan R, Desouza LV, Matta A, Chandra Tripathi S, Ghanny S, Datta Gupta S, et al. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography and tandem mass spectrometry. Mol Cell Proteomics 2008; 7:1162-73; http://dx.doi.org/10.1074/mcp.M700500-MCP200.
25. Shadeo A, Chari R, Lonergan KM, Pusic A, Miller D, Ehlen T, et al. Upregulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics 2008; 9:64; http://dx.doi.org/10.1186/1471-2164-9-64.
26. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, et al. BRG1, a component of the SWISNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000; 60:6171-7.
27. Chen J, Archer TK. Regulating SWI/SNF subunit levels via protein-protein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol 2005; 25:9016-27; http://dx.doi.org/10.1128/MCB.25.20.9016-27.2005.
28. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, et al. The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 1994; 79:119-30; http://dx.doi.org/10.1016/0092-8674(94)90405-7.
29. Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E, Cyclin E. Associates with BAF155 and BRG1, Components of the Mammalian SWI/SNF Complex, and Alters the Ability of BRG1 to Induce Growth Arrest. Mol Cell Biol 1999; 19:1460-9.
30. Stober B, Dunaief J, Guha S, Goff SP. Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins. Mol Cell Biol 1996; 16:1576-83.
31. Wong AK, Shanahan F, Chen Y, Lian L, Ha P, Hendricks K, et al. BRG1, a component of the SWI/ SNF complex, is mutated in multiple human tumor cell lines. Cancer Res 2000; 60:6171-7.
32. Laurent BC, Treitel MA, Carlson M. Functional interdependence of the yeast SNF2, SNF5 and SNF6 proteins in transcriptional activation. Proc Natl Acad Sci USA 1991; 88:2687-91; http://dx.doi.org/10.1073/pnas.88.7.2687.
33. Peterson CL, Herskowitz I. Characterization of the yeast SWI1, SWI2 and SWI3 genes, which encode a global activator of transcription. Cell 1992; 68:573-83; http://dx.doi.org/10.1016/0092-8674(92)90192-F.
34. INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 2005; 65:10192-8; http://dx.doi.org/10.1158/0008-5472.CAN-05-1896.
35. Yan Z, Wang Z, Sharova L, Sharov AA, Ling C, Piao Y, et al. BAF250B-associated SWI/SNF chromatinremodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 2008; 26:1155-65; http://dx.doi.org/10.1634/stemcells.2007-0846.
36. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93:691-9; http://dx.doi.org/10.1093/jnci/93.9.691.
37. Dammann R, Schagdarsurengin U, Liu L, Otto N, Gimm O, Dralle H, et al. Frequent RASSF1A promoter hypermethylation and K-ras mutations in pancreatic carcinoma. Oncogene 2003; 22:3806-12; http://dx.doi.org/10.1038/sj.onc.1206582.
38. Ji L, Minna J, Roth J. 3p21.3 tumor suppressor cluster: prospects for translational applicaitons. Future Oncol 2005; 1:79-92; http://dx.doi.org/10.1517/14796694.1.1.79.
39. Uno F, Sasaki J, Nishizaki M, Carboni G, Xu K, Atkinson EN, et al. Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells. Cancer Res 2004; 64:2969-76; http://dx.doi.org/10.1158/0008-5472.CAN-03-3702.
40. Chen J, Archer T. Regulating SWI/SNF Subunit Levels via Protein-Protein Interactions and Proteosomal Degradation: BAF155 and BAF170 Limit Expression of BAF57. Mol Cell Biol 2005; 25:9016-27; http://dx.doi.org/10.1128/MCB.25.20.9016-27.2005.
41. Sohn DH, Lee KY, Lee C, Oh J, Chung H, Jeon SH, et al. SRG3 interacts directly with the major components of the SWI/SNF chromatin remodeling complex and protects them from proteasomal degradation. J Biol Chem 2007; 282:10614-24; http://dx.doi.org/10.1074/jbc.M610563200.
42. Crosby MA, Miller C, Alon T, Watson KL, Verrijzer CP, Goldman-Levi R, et al. The trithorax group gene moira encodes a brahma-associated putative chromatinremodeling factor in Drosophila melanogaster. Mol Cell Biol 1999; 19:1159-70.
43. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et al. ARID1A mutations in endometriosis- associated ovarian carcinomas. N Engl J Med 2010; 363:1532-43; http://dx.doi.org/10.1056/NEJMoa1008433.
44. Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, Roden R, et al. Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010; 330:228-31; http://dx.doi.org/10.1126/science.1196333.
45. Varela I, Tarpey P, Raine K, Huang D, Ong CK, Stephens P, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011; 469:539-42; http://dx.doi.org/10.1038/nature09639.
46. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2a). EMBO J 1998; 17:6979-91 http://dx.doi.org/10.1093/emboj/17.23.6979.
47. Weissman B, Stanbridge EJ. Characterization of ouabain-resistant, hypoxanthine guanine phosphoribosyl transferase-deficient human cells and their usefulness as a general method for the production of human cell hybrids. Cytogenet Cell Genet 1980; 28:227-39 http://dx.doi.org/10.1159/000131536.
48. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. Biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7; http://dx.doi.org/10.1073/pnas.92.20.9363.
49. WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res 2001; 61:7754-62.